Dear Shareholders,
Your Directors have the pleasure of presenting the 16th
Annual Report of Chemfab Alkalis Limited along with the Audited Standalone and
consolidated financial statements for thest March 2025.
The summarized financial results are as under:
FINANCIAL SUMMARY
( Rs In Lakhs)
Particulars |
Consolidated |
Standalone |
|
Year ended. 31 March 2025 |
Year ended. 31 March 2024 |
Year ended. 31 March 2025 |
Year ended. 31 March 2024 |
Summary of Profit and Loss Statement: |
|
|
|
|
Total Revenue |
33,437.43 |
32,729.68 |
32,209.05 |
32,728.78 |
Profit before Finance Cost and Depreciation |
5,083.86 |
6,243.95 |
5,913.59 |
6,540.77 |
Less: Finance Cost |
492.50 |
94.22 |
491.58 |
93.08 |
Profit before Depreciation |
4,591.36 |
6,149.73 |
5,422.01 |
6,447.69 |
Less: Depreciation and amortization |
3,633.13 |
2,235.08 |
3,238.79 |
2,185.01 |
Profit Before Exceptional Items |
958.23 |
3,914.65 |
2,183.22 |
4,262.68 |
Exceptional Items |
(988.77) |
- |
- |
- |
Profit before Tax |
(30.54) |
3,914.65 |
2,183.22 |
4,262.68 |
Less: Tax including Deferred Tax |
663.49 |
1,282.34 |
660.80 |
1,263.96 |
Profit/(Loss) after |
(694.03) |
2,632.31 |
1,522.42 |
2,998.72 |
Other Comprehensive Income/(Loss) |
38.43 |
21.94 |
38.43 |
21.94 |
Total Comprehensive Income/(Loss) |
(655.60) |
2,654.25 |
1,560.85 |
3,020.66 |
Summary of Retained Earnings Movement: |
|
|
|
|
Balance brought forward from last year |
1,150.48 |
(1,320.62) |
1,712.98 |
(1,124.53) |
Add: Profit/(Loss) after |
(694.03) |
2,632.31 |
1,522.42 |
2,998.72 |
Add: Other Comprehensive Income |
41.19 |
16.20 |
41.19 |
16.20 |
Less: Appropriations |
|
|
|
|
Final Dividend |
178.46 |
177.41 |
178.46 |
177.41 |
Tax on Dividend |
- |
- |
|
- |
Balance Carried to Balance Sheet |
319.18 |
1,150.48 |
3,098.13 |
1,712.98 |
Performance and State of Affairs of the Company
The overall performance and more details are covered under the
Management section, which forms part of the Annual Report.
Change in Nature of Business
During the year under review, there is no change in nature of business
of your Company.
Change in the registered office of the
Company
There was no change in the registered office of the company during the
financial year 2024-2025.
Capital Structure
During the year under consideration, there is no change in authorized
share capital. However, the paid-up share capital was increased due to allotment of equity
shares under Company's employee stock option scheme "CAESOS 2020". As on 31st
March 2025, the authorised and paid - up capital stands as stated below: The
Authorized Share Capital of the Company is Rs39,14,00,000 (Rupees Thirty Nine Crores
Fourteen Lakhs Only) divided into 3,91,40,000 (Rupees Three Crores Ninety-One Lakh Forty
Thousand Only) Equity Shares of Rs10/- each.
The Paid-up Share capital of the Company stands at Rs14,36,37,020
(Rupees Fourteen Crore Thirty Six Lakh Thirty Seven Thousand Twenty Only) divided into
1,43,63,702 (Rupees One Crore Forty Three Lakh Sixty Three Thousand Seven Hundred Two
Only) Equity Shares of Rs10/- each.
Dividend
Your directors recommended the payment of Dividend of Rs1.25/- per
share for the year ended March 31, 2025, absorbing a sum of Rs179.55 Lakhs considering
shares outstanding as on 31 March 2025, subject to the approval of the Members at the
ensuing Annual General Meeting.
Transfer of profit to reserves
The Company has not proposed transferring any of its profits to
reserves.
Material Changes during the reporting period
No material changes have occurred, or any commitments made between the
financial year ended 31st March 2025 and the date of this report, which would
adversely affect the financial position of the company.
BOARD OF DIRECTORS AND ITS COMMITTEES
A. Composition of the Board of Directors
The Board of Directors of the Company comprise of total eight directors
including Non- Executive Chairman who is a promoter of the Company, Non - Executive
Directors and Independent Directors. The Company has two women Independent Directors. The
composition of the Board of Directors is in compliance with Regulation 17(1)(b) of SEBI
(Listing Obligations and Disclosure Requirements) Regulations 2015 and Section 149 of the
Companies Act, 2013.
The Company has received necessary declarations from the Independent
Directors under Section 149(7) of the Companies Act, 2013 stating that they meet the
criteria of independence as specified in Section
149(6) of the Companies Act, 2013 and as per the SEBI
(Listing Obligations and Disclosures Requirements)
Regulations, 2015.
The Independent Directors are registered with the data bank as per rule
6 of the Companies (Appointment and
Qualification of Directors) Fifth Amendment Rules, 2019.The
Registration details are as below:
Sl. No |
Name of the Director |
Registration number |
01. |
Mr. A. Janakiraman |
IDDB-DI-202002-007989 |
02. |
Mrs. J. Sujatha Jayarajan |
IDDB-DI-201912-001692 |
03. |
Mrs. R. Drushti Desai |
IDDB-DI-202002-015500 |
04. |
Mr. Satish Narain Jajoo (Additional) (w.e.f. 30th
May, 2025) |
IDDB-DI-202110-039184 |
Board Composition:
The Board is well balanced with the composition of four Non-
Independent Directors and Four Independent Directors (including two Women Independent
directors).
Category |
Name of Directors |
Non Independent Directors |
Mr. Suresh Krishnamurthi Rao |
|
Mr. C S Ramesh |
|
Mr. R Mahendran |
|
Mr. Nitin S Cowlagi |
Independent Directors |
Mr. A Janakiraman |
|
Mrs. Drushti Desai |
|
Mrs. Sujatha Jayarajan |
|
Mr. Satish Narain Jajoo (Additional) (w.e.f. 30th
May, 2025) |
Thus, the composition of the Board is in line with the terms of Section
149 of the Companies Act 2013 and
Regulations 17(1)(b) of the SEBI (LODR) Regulations, 2015.
B. Meetings
The number of Board Meetings held during the year along with the dates
of the meetings:
(Disclosure pursuant to 134 (3)(b) of the Companies Act, 2013).
During the Financial Year 2024-2025, the Board of Chemfab Alkalis
Limited met Five times as under:
Sl. No |
Date of Board meetings |
Quarter |
No. of Directors as on the date of
Meeting |
Total No. of Directors attended |
1. |
22nd May 2024 |
First |
7 |
7 |
2. |
08th August 2024 |
Second |
7 |
7 |
3. |
25th September 2024 |
Second |
7 |
5 |
4. |
04th November 2024 |
Third |
7 |
7 |
5. |
30th January 2025 |
Fourth |
7 |
7 |
The meetings of the Board were held periodically, with an interval of
not more than one hundred and twenty days between two consecutive meetings, as prescribed
under Section 173(1) of the Act.
C. Re-appointment of Directors Retiring by Rotation
In terms of Section 152 of the Companies Act, 2013, Mr. R. Mahendran
(DIN: 07451058) is liable to retire by rotation at the ensuing Annual General Meeting and
being eligible, offers himself for re-appointment. The Board of Directors, based on the
recommendation of the Nomination and Remuneration Committee has recommended the
re-appointment of Mr. R. Mahendran (DIN: 07451058) retiring by rotation.
D. Committees of the Board
The constitution and terms of reference of the Audit Committee,
Nomination and Remuneration Committee, Stakeholders Relationship Committee, Corporate
Social Responsibility Committee, and Risk Management Committee are also aligned with the
requirements of Regulations 18 to 22 of SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015 and the Companies Act, 2013.
A detailed note on the Committees is given in the Corporate Governance
Report forming part of the Annual Report.
E. Performance Evaluation
Section 134 of the Companies Act, 2013 states that formal evaluation
needs to be made by the Board, of its performance and that of its committees and the
individual Directors. Schedule IV of the Companies Act, 2013 and regulation 17(10) of SEBI
(Listing Obligations and Disclosure Requirements) Regulations, 2015 state that the
performance evaluation of each Independent Director shall be done by the entire Board of
Directors excluding the Director being evaluated.
Pursuant to the provisions of Section 134 (3) (p) of the Companies Act,
2013 and SEBI (LODR) regulations,
2015, the Board has carried out an evaluation of its performance, the
Directors individually as well as its Committees. The manner in which the evaluation has
been carried out has been explained in the Corporate Governance Report forming part of the
Annual Report.
F. Directors' Responsibility Statement
As required under Section 134(5) of the Companies
Act, 2013, the Board of Directors hereby confirms, that -
(a) In the preparation of the Annual Accounts for the financial year
ended 31st March 2025, the applicable Accounting Standards and Schedule III of
the Act have been followed and there are no material departures.
(b) They have selected such accounting policies and applied them
consistently and made judgments and estimates that are reasonable and prudent to give a
true and fair view of the state of affairs of the Company at the end of the financial year
and of the loss of the Company for the financial year 2024-2025.
(c) They have taken proper and sufficient care for the maintenance of
adequate accounting records in accordance with the provisions of the Act for safeguarding
the assets of the Company and for preventing and detecting fraud and other irregularities.
(d) They have prepared the annual accounts on a going-concern basis.
(e) They have laid down proper internal financial controls to be
followed by the Company and such internal financial controls are adequate and are
operating effectively; and
(f) They have devised proper systems to ensure compliance with the
provisions of all applicable laws and that such systems are adequate and operating
effectively.
G. Changes in Directors and Key Managerial Personnel
During the year under review there were no changes in Directors or Key
Managerial Personnel. After the end of financial year, Mr. Satish Narain Jajoo was
appointed as Additional Director (Independent) w.e.f. 30th May, 2025. Mr. B.
Vignesh Ram resigned from the position of Company Secretary and Compliance Officer on 18 th
April, 2025 and Mr. Bharatraj Panchal was appointed as Company Secretary and Compliance
Officer w.e.f. 16th July, 2025.
H. Changes in Subsidiaries, Joint Ventures, and Associates
During the financial year ended 31st March 2025, there were
no changes in the subsidiaries, joint ventures and associates. The salient feature on
financial statements or performance is given in Annexure A of this report.
I. Significant or Material Orders Passed by
Regulators/Courts passedThere were no significant by any
regulator/court during the reporting period.
J. Declaration by Independent Directors
The Company has received necessary declarations from Mr. A.
Janakiraman, Mrs. Sujatha Jayarajan, and Mrs. Drushti Desai independent directors, under
Section 149 (7) of the Companies Act 2013, that they meet the criteria of independence
laid down in Section 149(6) of the Companies Act 2013 and regulation 25 of the
SEBI (Listing Obligations and Disclosure Requirements)
Regulations 2015 and their Declarations have been taken on record.
K. Independent Directors' Meeting
In accordance with the provisions of Schedule IV (Code for Independent
Directors) of the Companies Act, 2013 and Regulation 25 of the SEBI Listing Regulations, a
meeting of the Independent Directors of the Company was held on March 29, 2025 without the
presence of Non-Independent Directors and Company's Management.
The Company Secretary was an invitee to the said meeting and acted as a
facilitator to the Independent Directors.
L. Details in respect of Frauds
The Company's auditors' report does not have any statement on
suspected fraud in the company's operations to explain as per Sec. 134(3) (ca) of the
Companies Act 2013.
M. Fixed Deposits
During the year under review, the Company did not raise funds, by way
of fixed deposits, from the public.
N. Details of contracts or arrangements with related parties
The details of contracts or arrangements entered into with related
parties along with justification for entering into such contract or arrangement, referred
to in subsection (1) of Section 188 in the prescribed form no. AOC 2 is given in Annexure
B of this report.
O. Code of Conduct for prevention of Insider Trading
The Company has a policy viz., "Code of Conduct for prevention of
Insider Trading" and the same has been posted on its website www.chemfabalkalis.com.
The Company also monitors insider trading activities through Structured digital database
software in accordance with Regulation 5(3) of SEBI (LODR)
(Amendment) Regulations 2020.
P. Development and implementation of a Risk Management Policy
ThemainobjectiveofRiskManagementisriskreduction and avoidance, as also
identification of the risks faced by the business and optimizing the risk management
strategies. The Company has put in place a well-defined Risk Management framework. The
Company has constituted a Risk Management Committee even though the constitution of the
same does NOT apply to the Company since it is mandatory only for the top 1000 listed
Companies as per the listing regulations. The Risk Management Committee assists the Board
in drawing up, implementing, monitoring, and reviewing the Risk Management Plan. The
Committee lays down the Risk Assessment and Minimization Procedures and it reviews the
Procedures periodically to ensure that the Executive Management controls the risks through
a properly defined framework.
The Company has also obtained certification for ISO 14001 and ISO 45001
systems to take care of critical operational areas. The Company has also implemented
Process Safety Management (PSM). We are the first company in our industry to implement the
same.
We are continuing with the publishing of a sustainability report,
enhancing our commitment to sustainable development.
Q. Technology absorption, Conservation of energy and Research and
development and Foreign Exchange earning and Outgo
The detailed note on the technical absorption and conversation of
energy and research and development and Foreign Exchange earning and Outgo is annexed
herewith as Annexure C.
R. Cost Records
Your Company is maintaining cost records and reports pursuant to the
Companies (Cost Records and Audit) Rules, 2014, as amended prescribed by the Central
Government under sub-section (1) of Section 148 of the Companies Act, 2013.
AUDIT RELATED MATTERS
A. Statutory Auditors
M/s. Deloitte Haskins & Sells LLP (Firm Registration No
117366W/W-100018) were re-appointed as Statutory Auditors of the
Company for a term of 4 (four) years, to hold office from the conclusion of the 13 th
Annual General Meeting held on 15th September 2022 till the conclusion of the
17th Annual General Meeting on such professional fees as may be fixed by the
Board of Directors as recommended by the Audit Committee in consultation with them.
There are no qualifications or adverse remarks in the
Statutory Audit Report which require any explanation from the Board of
Directors.
B. Cost Auditor
As per Sec. 148 (6) of Companies Act, 2013 and rule 6(6) of the
Companies (Cost Records and Audit) Rules, 2014, the applicability of Cost audit is based
on the overall annual turnover of the company, from all its products and services during
the immediately preceding financial year, being rupees one hundred crores or more. Under
Rule 3 of the same Regulations, the maintenance of cost records applies to companies whose
aggregate turnover of the individual product or products, or service or services is Rupees
thirty-five crores or more.
In conformity with the said provisions of the Companies Act, 2013, the
Company has appointed M/s. Madhavan, Mohan & Associates, Cost Auditors, as the Cost
Auditor, for the audit of cost accounts for your Company for the year ending 31st
March 2025.
The remuneration to be paid to him is being ratifiedat this Annual
General meeting.
There are no qualifications or adverse remarks in the
Cost Audit Report which require any explanation from the Board of
Directors.
C. Secretarial Audit Report
Pursuant to Section 204 of the Companies Act, 2013 and the Companies
(Appointment and Remuneration of Managerial Personnel) Rules, 2014, your Company has
appointed M/s. M Damodaran & Associates LLP,
Practicing Company Secretaries to undertake the Secretarial Audit of
the Company. The Secretarial Audit Report in Form No. MR-3 for the financial year
2024-2025, is annexed herewith, as Annexure F.
A Certificate from a Company Secretary in practice that none of the
directors on the board of the company have been debarred or disqualified from being
appointed or continuing as directors of companies by the Board/Ministry of Corporate
Affairs or any such statutory authority is annexed herewith, as Annexure G.
During the financial year ended 31 st March, 2025, the
following observations were submitted from the Secretarial Auditor of the Company that
needs the response of the Board.
1. As per Regulation 17(1) (b) of SEBI LODR, where the regular
non-executive chairperson is a promoter of the listed entity, at least half of the board
of directors of the listed entity shall consist of independent directors.
"During the review period, the listed entity had 3 independent
directors out of total 7 directors."
Response from the Board of Directors: The listed entity has
complied with said regulation 17(1) (b) of SEBI LODR by appointing one more independent
director in the Board as on date of Secretarial Audit Report.
2. As per Regulation 18(1) (b) of SEBI LODR, every listed entity shall
constitute a qualified and independent audit committee with at least two-thirds of the
members of audit committee shall be independent directors.
"The Audit Committee was not constituted with at least two-thirds
of the independent directors during the period from April 01, 2024 to September
24, 2024 as required u/r. 18(1) (b) of SEBI LODR."
Response from the Board of Directors: The Company has reconstituted
the Audit Committee in compliance with regulation 18 (1) (b) of SEBI LODR as on date of
Secretarial Audit Report.
The Company has paid fine amounting to Rs3,56,000 as imposed by NSE
under protest and fine of Rs4,20,080 as imposed by BSE is subject to protest.
Pursuant to the provisions of Regulation 24A and other applicable
provisions, if any, of the SEBI Listing
Regulations, read with Section 204 of the Companies Act, 2013 and the
Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014, and based on
the recommendation of the Audit Committee, the Board of Directors, at their meeting held
on May 14, 2025, approved the appointment of M/s. M. Damodaran & Associates LLP,
practicing Company Secretaries (Firm Registration Number: L2019TN006000), a peer-reviewed
practicing Company Secretaries, as the Secretarial Auditor of the Company for a first term
of five consecutive years commencing from the Financial Year 2025-26 to Financial Year
2029-30, subject to the approval of the shareholders at the ensuing AGM.
D. Internal Financial Controls
Your Company has well-defined and adequate internal controls and
procedures, commensurate with its size and the nature of its operations. This is further
strengthened by the Internal Audit done concurrently. During the year, the Company got its
internal controls over financial reporting and risk management process evaluated by
independent consultants.
Besides, the Company has an Audit Committee, comprising Independent and
Non-Executive Directors, which monitors systems, controls, financial management, and
operations of the Company.
The Audit Committee has evaluated the internal financial controls and
risk management system at its meeting held on the following dates
Sl. No. |
Date of Meeting |
1. |
22nd May 2024 |
2. |
08th August 2024 |
3. |
04th November 2024 |
4. |
30th January 2025 |
E. Internal Auditor
The Board appointed M/s. V Sankar Aiyar & Co, Chartered
Accountants, as an internal auditor for the Financial Year 2024-2025 based on the
recommendations of the Audit Committee.
BOARD COMMITTEE COMPOSITION
The Board has constituted the following committees viz. Audit
Committee, Nomination and Remuneration Committee, Stakeholders Relationship Committee,
Corporate Social Responsibility Committee, and Risk Management Committee.
A. Audit Committee
Pursuant to regulation 18 of SEBI (LODR) Regulations
2015 and the provision of Section 177(8) read with Rule 6 of the
Companies (Meeting of Board and its Powers) Rules 2014, the Company has duly constituted a
qualified and independent Audit Committee. The Audit
Committee of the Board consists of four "Independent
Directors" and Two "Non Independent Directors" as members having
adequate financial and accounting knowledge. The composition, procedures, powers, and
role/functions of the audit committee and its terms of reference are set out in the
Corporate Governance Report forming part of the Boards Report.
During the period under review, the suggestions put forth by the Audit
Committee were duly considered and accepted by the Board of Directors. There were no
instances of non-acceptance of such recommendations.
The Audit Committee acts in accordance with the terms of reference
specified by the Board of Directors in terms of Section 177(4) of the Act and in terms of
Regulation 18 of the SEBI (LODR) Regulations, 2015. It also oversees
the vigil mechanism and is obliged to take suitable action against the Directors or
employees concerned, when necessary.
A detailed note on the Audit Committee is given in the Corporate
Governance Report forming part of the Annual Report.
B.NominationandRemunerationCommittee
According to Section 178 of the Companies Act, 2013 and in terms of
Regulation 19 of SEBI (LODR) Regulations,
2015, the Company has set up a Nomination and Remuneration Committee
which has formulated the criteria for determining the qualifications, attributes, and
independence of a Director and ensures that:
1) The level and composition of remuneration are reasonable and
sufficient to attract, retain and motivate Directors having the quality required to run
the Company successfully.
2) The relationship of remuneration to performance is clear and meets
appropriate performance benchmarks; and
3) Remuneration to Directors, key managerial personnel, and senior
management involves a balance between fixed and variable pay, reflecting short-term and
long-term performance, objectives appropriate to the working of the Company and its goals.
The Nomination and Remuneration Policy of your Company is set out and
available on your company website www.chemfabalkalis.com. A detailed note on the
Nomination and Remuneration Committee is given in the Corporate Governance Report forming
part of the Annual Report.
C. Stakeholders' Relationship Committee
A detailed note on the Stake Holders' Relationship
Committee is given in the Corporate Governance Report forming part of
the Annual Report.
D. Risk Management Committee
The Company has constituted a Risk Management Committee even though the
constitution of Risk Management Committee does NOT apply to the Company since it is
mandatory only for the top 1000 listed Companies as per the listing regulations. The Risk
Management Committee assists the Board in drawing up, implementing, monitoring, and
reviewing the Risk Management Plan. The Committee lays down Risk Assessment and
Minimization Procedures and it reviews the Procedures periodically to ensure that the
Executive Management controls the risks through the properly defined framework.
E. Corporate Social Responsibility (CSR) Committee
The Board has constituted the Corporate Social Responsibility Committee
in accordance with Section 135 of the Companies Act, 2013. The Company is committed to
operating in a socially responsible manner in terms of protecting the environment and
conserving water resources and energy. Details of the CSR Policy drawn up by the Company
and the CSR expenditure and initiatives were taken during the year 2024-25 are given in Annexure
D to this Report.
OTHER MATTERS
A. Particulars of loans, guarantees, or investments u/s 186 of the
Companies Act, 2013
During the year under review, the details of loans, guarantees or
investments u/s 186 of the Companies
Act 2013 forms part of the financial statements for financial year
ended 31 st March, 2025 which includes the Loan of Rs3,800 Lakhs (Principal
Rs3,761.43 Lakhs and interest at 8.80% net of TDS Rs38.57 Lakhs) which was subsequently
converted to Preference shares additionally the Company has invested Rs600 Lakhs towards
subscription of 0.01% Cumulative Convertible Preference Shares and the overall investment
is 4,40,00,000 shares of Rs10 each in Chemfab Alkalis
Karaikal Limited, a Wholly Owned Subsidiary.
B. Remuneration details of Directors and Employees
The Company's policy on Directors' appointment and
remuneration, including criteria for determining qualification, positive attributes and
independence of a director and other matters provided under subsection (3) of Section 178,
is posted on our company's website in the following link https://chemfabalkalis.
com/investors/ and forms part of this Report pursuant to the first proviso of Sec. 178 of
the Companies Act 2013.
C. Debentures
During the year under review, the Company has not issued any
debentures. As of date, the Company does not have any outstanding debentures.
D. Bonus Shares
During the year under review, the Company has not issued any bonus
shares.
E. Borrowings
The Company has outstanding borrowings including IND AS accounting
adjustment entries and interest accrued of Rs8,101.34 Lakhs during the financial Year
ended March 31, 2025.
F. Deposits
The Company has not accepted any deposits in terms of Chapter V of the
Companies Act, 2013 read with the Companies (Acceptance of Deposit) Rules, 2014, during
the year under review and as such, no amount on account of principal or interest on public
deposits was outstanding as of the balance sheet date.
G. Transfer to Investor Education and Protection Fund
The details of the transfer of unclaimed dividends and the shares for
seven consecutive years to the Investor Education and Protection Fund are given in the
Corporate Governance Report forming part of the Annual Report, which is also available on
the company's website.
H. Credit Ratings
India Ratings has assigned initial rating of "IND A-/
Stable" for Long term Bank facilities; and "IND A2+" for
Short term Bank facilities.
I. Code of Corporate Governance
In compliance with the requirement of regulations
24 to 27 of SEBI (Listing Obligations and Disclosures
Requirements) Regulations, 2015, a detailed report on Corporate
Governance is annexed to this report as Annexure H along with a Certificate M/s. M.
Damodaran & Associates LLP, Practicing Company Secretaries, Chennai affirming
compliance with the said Code which is appended as Annexure I.
J. Code of conduct for Directors and Senior Management
The Board of Directors had adopted a code of conduct for the Board
Members and employees of the company. This Code helps the Company to maintain the standard
of Business Ethics and ensure compliance with the legal requirements of the Company.
The Code is aimed at preventing any misconduct and promoting ethical
conduct at the Board level and by employees. The Compliance Officer is responsible to
ensure adherence to the Code by all concerned.
The Code lays down the standard of conduct which is expected to be
followed by the Directors and the designated employees in their business dealings and in
particular on matters relating to integrity in the workplace, in business practices, and
in dealing with stakeholders.
All the Board Members and the Senior Management personnel have
confirmed compliance with the Code.
K. Management Discussion and Analysis Report
In accordance with the requirement of the Listing Regulations, the
Management Discussion and Analysis Report is presented in a separate section, which forms
an integral part of this Annual Report.
L. Disclosure on Sexual Harassment of Women at Workplace (Prevention,
Prohibition and Redressal) Act, 2013
The Company has in place a Sexual Harassment Policy in line with the
requirement of Sexual Harassment of Women at Workplace (Prevention, Prohibition and
Redressal) Act, 2013.
Internal Compliant Committee (ICC) has been set up to redress the
complaints received in connection with sexual harassment in any form.
All employees (permanent, contractual, temporary, trainees) are covered
under this policy.
a. Number of complaints filed during the financial year: NIL
b. Number of complaints disposed of during the financial year:NIL
c. Number of complaints pending as of the end of the financial year:NIL
M. Vigil Mechanism
The Company has established a vigil mechanism, also called the Whistle
Blower Policy, which has been adopted by the Board, applicable to Directors and employees,
to report concerns about unethical behaviour, actual or suspected fraud or violation of
the Company's Code of Conduct or Ethics Policy. It provides adequate safeguards
against victimization of persons who use such mechanism and makes provision for direct
access to the Chairperson of the Audit Committee in appropriate or exceptional cases. The
confidentiality of Whistle Blower shall be maintained to the greatest extent possible.
Details of the vigil mechanism are available on our
Company's website.
N. Annual Return MGT 7
As per the provisions of Section 134(3)(a) of the companies Act, 2013,
the Annual Return of the Company is available on our website at www.
chemfabalkalis.com/investors
O. Employees' Stock Option Scheme
The Company has adopted two Employees' Stock Option Schemes: i.
Chemfab Alkalis Employees' Stock Option Scheme
2015 ("CAESOS -2015") and
ii. Chemfab Alkalis Employees' Stock Option Scheme
2020 ("CAESOS -2020").
Your Company has received a certificate from the
Secretarial Auditors of the Company that ESOP Schemes viz., CAESOS
-2015 and CAESOS -2020 has been implemented in accordance with Regulation
13 of the SEBI (Share Based Employee Benefits)
Regulations, 2014 and the resolution(s) passed by the Members of the
Company
i. Chemfab Alkalis Employees' Stock Option Scheme 2015
The Shareholders of the Amalgamated entity
Chemfab Alkalis Limited had approved the Employees'
Stock Option Scheme titled "CAESOS 2015" through
Postal Ballot on March 05, 2016. "CAESOS-2015" complies with SEBI (Share Based
Employee Benefits)
Regulations, 2014. The details as required under the
SEBI regulations is part of the financial statements of this Annual
Report.
During the year under review, there were no ESOPs granted or equity
allotted upon conversion of option under said Plan.
ii. Chemfab Alkalis Employees' Stock Option Scheme 2020
At the 11th Annual General Meeting held on 29th
July 2020, the Shareholders approved Employee Stock
Option Scheme (CAESOS -2020') covering 4,00,000 equity
shares. There have been no material changes to the Scheme during the year under review.
The relevant disclosures pursuant to Rule 12 (9) of the Companies (Share Capital and
Debentures) Rules, 2014 and Regulation 14 of SEBI (Share Based Employee
Benefits) Regulations, 2014 is forming part of the financial statements
of this Annual report.
Your Company has received a certificate from the
Secretarial Auditors of the Company that ESOP Schemes viz., CAESOS
-2015 and CAESOS -2020 has been implemented in accordance with Regulation
13 of the SEBI (Share Based Employee Benefits)
Regulations, 2014 and the resolution(s) passed by the Members of the
Company is given in Annexure J.
During the Financial Year 2024-2025 the Company has allotted 1,37,100
equity shares under CAESOS -2020' scheme.
P. Green initiatives
Pursuant to the Ministry of Corporate Affairs (MCA) circulars dated
April 08, 2020, April 13, 2020, and May 05, 2020, and other circulars issued from time to
time, the Company is providing the facility of remote e-voting to its members in respect
of the business to be transacted at the AGM. Electronic copies of the Annual Report
2024-2025 and Notice of the fourteen (16th) Annual General Meeting are sent to
all the members whose email addresses are registered with the Company/Depository
Participant(s). Further, the soft copy of the Annual Report (in pdf format) is also
available on our website https://chemfabalkalis.com/ investors/
Pursuant to Section 108 of the Companies Act, 2013, Rule 20 of the
Companies (Management and
Administration) Rules, 2014, and Listing Regulations, the Company is
providing an e-voting facility to all members to enable them or their nominees to cast
their votes electronically on all resolutions outlined in the notice. The instructions for
e-voting are provided in the notice.
Q. Statement on Secretarial Standards
The Company is adopting compliances of applicable secretarial standards
and other secretarial standards to ensure good governance.
R. Human Resources
Employee relations continue to be cordial and harmonious at all levels
and in all the divisions of the
Company. The Board of Directors would like to express their sincere
appreciation to all the employees for their continued hard work and dedication.
The number of Direct employees as of March 31, 2025, was 213. The table
containing the names and other particulars of employees in accordance with the provisions
of Section 197(12) of the Companies Act, 2013, read with Rule 5(1) and 5 (2) of the
Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014, is appended
as Annexure E to the Board's Report.
S. Details of application made or proceedings under IBC 2016 during the
year
The Company has not applied any application under Insolvency and
Bankruptcy code,2016.
T. Details of one-time settlement and the valuation done while taking
loan from Banks and Financial Institutions
The company has not entered into a one-time settlement with any Banks
& Financial Institutions during the Financial Year 2024-25.
ACKNOWLEDGMENT
The Directors thank the Shareholders, Customers, Dealers, Suppliers,
Bankers, Financial Institutions and all other business associates for their continued
support to the Company and the confidence reposed in its Management. The Directors also
thank the Government authorities for their cooperation. The Directors wish to record their
sincere appreciation of the significant contribution made by the CCAL mates at all levels
to its successful operations.
|
By Order of the Board of Directors |
|
For Chemfab Alkalis Limited |
|
Sd/- |
|
Suresh Krishnamurthi Rao, |
Place: Chennai |
Chairman |
Date: 31st July 2025 |
DIN: 00127809 |